These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 21047515

  • 21. Age- and strain-related aberrant Ca2+ release is associated with sudden cardiac death in the ACTC E99K mouse model of hypertrophic cardiomyopathy.
    Rowlands CT, Owen T, Lawal S, Cao S, Pandey SS, Yang HY, Song W, Wilkinson R, Alvarez-Laviada A, Gehmlich K, Marston SB, MacLeod KT.
    Am J Physiol Heart Circ Physiol; 2017 Dec 01; 313(6):H1213-H1226. PubMed ID: 28887330
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. alpha-Tropomyosin mutations Asp(175)Asn and Glu(180)Gly affect cardiac function in transgenic rats in different ways.
    Wernicke D, Thiel C, Duja-Isac CM, Essin KV, Spindler M, Nunez DJ, Plehm R, Wessel N, Hammes A, Edwards RJ, Lippoldt A, Zacharias U, Strömer H, Neubauer S, Davies MJ, Morano I, Thierfelder L.
    Am J Physiol Regul Integr Comp Physiol; 2004 Sep 01; 287(3):R685-95. PubMed ID: 15031138
    [Abstract] [Full Text] [Related]

  • 26. Influence of a constitutive increase in myofilament Ca(2+)-sensitivity on Ca(2+)-fluxes and contraction of mouse heart ventricular myocytes.
    Puglisi JL, Goldspink PH, Gomes AV, Utter MS, Bers DM, Solaro RJ.
    Arch Biochem Biophys; 2014 Jun 15; 552-553():50-9. PubMed ID: 24480308
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. PKA accelerates rate of force development in murine skinned myocardium expressing alpha- or beta-tropomyosin.
    Patel JR, Fitzsimons DP, Buck SH, Muthuchamy M, Wieczorek DF, Moss RL.
    Am J Physiol Heart Circ Physiol; 2001 Jun 15; 280(6):H2732-9. PubMed ID: 11356630
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.
    Olsson MC, Palmer BM, Stauffer BL, Leinwand LA, Moore RL.
    Circ Res; 2004 Feb 06; 94(2):201-7. PubMed ID: 14670849
    [Abstract] [Full Text] [Related]

  • 32. Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling.
    Knollmann BC, Kirchhof P, Sirenko SG, Degen H, Greene AE, Schober T, Mackow JC, Fabritz L, Potter JD, Morad M.
    Circ Res; 2003 Mar 07; 92(4):428-36. PubMed ID: 12600890
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Long-range effects of familial hypertrophic cardiomyopathy mutations E180G and D175N on the properties of tropomyosin.
    Ly S, Lehrer SS.
    Biochemistry; 2012 Aug 14; 51(32):6413-20. PubMed ID: 22794249
    [Abstract] [Full Text] [Related]

  • 35. Lys184 deletion in troponin I impairs relaxation kinetics and induces hypercontractility in murine cardiac myofibrils.
    Iorga B, Blaudeck N, Solzin J, Neulen A, Stehle I, Lopez Davila AJ, Pfitzer G, Stehle R.
    Cardiovasc Res; 2008 Mar 01; 77(4):676-86. PubMed ID: 18096573
    [Abstract] [Full Text] [Related]

  • 36. F110I and R278C troponin T mutations that cause familial hypertrophic cardiomyopathy affect muscle contraction in transgenic mice and reconstituted human cardiac fibers.
    Hernandez OM, Szczesna-Cordary D, Knollmann BC, Miller T, Bell M, Zhao J, Sirenko SG, Diaz Z, Guzman G, Xu Y, Wang Y, Kerrick WG, Potter JD.
    J Biol Chem; 2005 Nov 04; 280(44):37183-94. PubMed ID: 16115869
    [Abstract] [Full Text] [Related]

  • 37. Hypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in mice.
    Huang W, Liang J, Kazmierczak K, Muthu P, Duggal D, Farman GP, Sorensen L, Pozios I, Abraham TP, Moore JR, Borejdo J, Szczesna-Cordary D.
    J Mol Cell Cardiol; 2014 Sep 04; 74():318-29. PubMed ID: 24992035
    [Abstract] [Full Text] [Related]

  • 38. Alterations of tension-dependent ATP utilization in a transgenic rat model of hypertrophic cardiomyopathy.
    Frey N, Brixius K, Schwinger RH, Benis T, Karpowski A, Lorenzen HP, Luedde M, Katus HA, Franz WM.
    J Biol Chem; 2006 Oct 06; 281(40):29575-82. PubMed ID: 16882671
    [Abstract] [Full Text] [Related]

  • 39. A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice.
    Prabhakar R, Boivin GP, Grupp IL, Hoit B, Arteaga G, Solaro RJ, Wieczorek DF.
    J Mol Cell Cardiol; 2001 Oct 06; 33(10):1815-28. PubMed ID: 11603924
    [Abstract] [Full Text] [Related]

  • 40. Temporal and mutation-specific alterations in Ca2+ homeostasis differentially determine the progression of cTnT-related cardiomyopathies in murine models.
    Guinto PJ, Haim TE, Dowell-Martino CC, Sibinga N, Tardiff JC.
    Am J Physiol Heart Circ Physiol; 2009 Aug 06; 297(2):H614-26. PubMed ID: 19502551
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.